Pharmaceutics · 2019 · 25 citations · 43 references
MedicineOncologyPharmacologyDrug DeliveryMolecular ImagingMolecular OncologyLigand BindingLigand-mediated TargetingNeuroendocrine Tumor TherapyReceptor-mediated TargetingSomatostatin Receptor ImagingTargeting LigandsCancer Targeting LigandsG-protein-coupled Receptor EndocytosisIn Vivo StudiesNeuroendocrine Tumor PharmacologySomatostatin Receptor TargetingTumor Targeting LigandsTumor Tissue TargetingTumor-targeted Ligands
Tumor targeting has emerged as an advantageous approach to improving the efficacy and safety of cytotoxic agents or radiolabeled ligands that do not preferentially accumulate in the tumor tissue. The somatostatin receptors (SSTRs) belong to the G-protein-coupled receptor superfamily and they are overexpressed in many neuroendocrine tumors (NETs). SSTRs can be efficiently targeted with octreotide, a cyclic octapeptide that is derived from native somatostatin. The conjugation of cargoes to octreotide represents an attractive approach for effective tumor targeting. In this study, we conjugated octreotide to cryptophycin, which is a highly cytotoxic depsipeptide, through the protease cleavable Val-Cit dipeptide linker using two different self-immolative moieties. The biological activity was investigated in vitro and the self-immolative part largely influenced the stability of the conjugates. Replacement of cryptophycin by the infrared cyanine dye Cy5.5 was exploited to elucidate the tumor targeting properties of the conjugates in vitro and in vivo. The compound efficiently and selectively internalized in cells overexpressing SSTR2 and accumulated in xenografts for a prolonged time. Our results on the in vivo properties indicate that octreotide may serve as an efficient delivery vehicle for tumor targeting.
43
Jean Claude Reubi, Beatrice Waser, Jean‐Claude Schaer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 651 citations
Medicine, Endocrinology, Oncology +11
Pharmaceuticals from cultured algae
Robert E. Schwartz, C. F. Hirsch, David F. Sesin et al. · Journal of Industrial Microbiology & Biotechnology · 1990 · 313 citations · Full text
Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
C.D. Smith, Xiu-Guo Zhang, Susan L. Mooberry et al. · PubMed · 1994 · 217 citations
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Renzo Cescato, Stefan Schulz, Beatrice Waser et al. · PubMed · 2006 · 186 citations